Published in Medical Letter on the CDC and FDA, March 6th, 2005
Subject to FDA approval, the amended agreement would permit First Horizon to launch the fenofibrate product in the first half of 2005.
SkyePharma PLC develops pharmaceutical products benefiting from drug delivery technologies that provide easier-to-use and more effective drug formulations.
There are now 9 approved products incorporating 3 from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA